BIOMAT Database Logo BIOMAT Database Logo

Design and synthesis of new 2-substituted-5-[2-(2-halobenzyloxy)phenyl]-1,3,4-oxadiazoles as anticonvulsant agents. 2008

Afshin Zarghi, and Zahra Hajimahdi, and Shohreh Mohebbi, and Hootesa Rashidi, and Sasan Mozaffari, and Sahar Sarraf, and Mehrdad Faizi, and Seyed Abbas Tabatabaee, and Abbas Shafiee
Department of Medicinal Chemistry, Shaheed Beheshti University of Medical Sciences, Tehran, Iran. azarghi@yahoo.com

A new series of 2-substituted-5-[2-(2-halobenzyloxy)phenyl]-1,3,4-oxadiazoles was designed and synthesized as anticonvulsant agents. Electroshock and pentylenetetrazole-induced lethal convulsion tests showed that the introduction of an amino group at position 2 of 1,3,4-oxadiazole ring and a fluoro substituent at ortho position of benzyloxy moiety had the best anticonvulsant activity. Our results showed that this effect is mediated through benzodiazepine receptors mechanism.

UI MeSH Term Description Entries
D007202 Indicators and Reagents Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant & Hackh's Chemical Dictionary, 5th ed, p301, p499) Indicator,Reagent,Reagents,Indicators,Reagents and Indicators
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D010069 Oxadiazoles Compounds containing five-membered heteroaromatic rings containing two carbons, two nitrogens, and one oxygen atom which exist in various regioisomeric forms. Oxadiazole
D010433 Pentylenetetrazole A pharmaceutical agent that displays activity as a central nervous system and respiratory stimulant. It is considered a non-competitive GAMMA-AMINOBUTYRIC ACID antagonist. Pentylenetetrazole has been used experimentally to study seizure phenomenon and to identify pharmaceuticals that may control seizure susceptibility. Leptazole,Pentamethylenetetrazole,Pentetrazole,Cardiazol,Corasol,Corazol,Corazole,Korazol,Korazole,Metrazol,Metrazole,Pentazol,Pentylenetetrazol
D011963 Receptors, GABA-A Cell surface proteins which bind GAMMA-AMINOBUTYRIC ACID and contain an integral membrane chloride channel. Each receptor is assembled as a pentamer from a pool of at least 19 different possible subunits. The receptors belong to a superfamily that share a common CYSTEINE loop. Benzodiazepine-Gaba Receptors,GABA-A Receptors,Receptors, Benzodiazepine,Receptors, Benzodiazepine-GABA,Receptors, Diazepam,Receptors, GABA-Benzodiazepine,Receptors, Muscimol,Benzodiazepine Receptor,Benzodiazepine Receptors,Benzodiazepine-GABA Receptor,Diazepam Receptor,Diazepam Receptors,GABA(A) Receptor,GABA-A Receptor,GABA-A Receptor alpha Subunit,GABA-A Receptor beta Subunit,GABA-A Receptor delta Subunit,GABA-A Receptor epsilon Subunit,GABA-A Receptor gamma Subunit,GABA-A Receptor rho Subunit,GABA-Benzodiazepine Receptor,GABA-Benzodiazepine Receptors,Muscimol Receptor,Muscimol Receptors,delta Subunit, GABA-A Receptor,epsilon Subunit, GABA-A Receptor,gamma-Aminobutyric Acid Subtype A Receptors,Benzodiazepine GABA Receptor,Benzodiazepine Gaba Receptors,GABA A Receptor,GABA A Receptor alpha Subunit,GABA A Receptor beta Subunit,GABA A Receptor delta Subunit,GABA A Receptor epsilon Subunit,GABA A Receptor gamma Subunit,GABA A Receptor rho Subunit,GABA A Receptors,GABA Benzodiazepine Receptor,GABA Benzodiazepine Receptors,Receptor, Benzodiazepine,Receptor, Benzodiazepine-GABA,Receptor, Diazepam,Receptor, GABA-A,Receptor, GABA-Benzodiazepine,Receptor, Muscimol,Receptors, Benzodiazepine GABA,Receptors, GABA A,Receptors, GABA Benzodiazepine,delta Subunit, GABA A Receptor,epsilon Subunit, GABA A Receptor,gamma Aminobutyric Acid Subtype A Receptors
D002627 Chemistry, Physical The study of CHEMICAL PHENOMENA and processes in terms of the underlying PHYSICAL PHENOMENA and processes. Physical Chemistry,Chemistries, Physical,Physical Chemistries
D003292 Convulsants Substances that act in the brain stem or spinal cord to produce tonic or clonic convulsions, often by removing normal inhibitory tone. They were formerly used to stimulate respiration or as antidotes to barbiturate overdose. They are now most commonly used as experimental tools. Convulsant,Convulsant Effect,Convulsant Effects,Effect, Convulsant,Effects, Convulsant
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004597 Electroshock Induction of a stress reaction in experimental subjects by means of an electrical shock; applies to either convulsive or non-convulsive states. Electroconvulsive Shock,Electroconvulsive Shocks,Electroshocks,Shock, Electroconvulsive,Shocks, Electroconvulsive

Related Publications

Afshin Zarghi, and Zahra Hajimahdi, and Shohreh Mohebbi, and Hootesa Rashidi, and Sasan Mozaffari, and Sahar Sarraf, and Mehrdad Faizi, and Seyed Abbas Tabatabaee, and Abbas Shafiee
Synthesis and anticonvulsant activity of new 2-substituted-5- [2-(2-fluorophenoxy)phenyl]-1,3,4-oxadiazoles and 1,2,4-triazoles.
December 2004, Bioorganic & medicinal chemistry letters,
Afshin Zarghi, and Zahra Hajimahdi, and Shohreh Mohebbi, and Hootesa Rashidi, and Sasan Mozaffari, and Sahar Sarraf, and Mehrdad Faizi, and Seyed Abbas Tabatabaee, and Abbas Shafiee
Synthesis and anticonvulsant activity of new 2-substituted-5-(2-benzyloxyphenyl)-1,3,4-oxadiazoles.
April 2005, Bioorganic & medicinal chemistry letters,
Afshin Zarghi, and Zahra Hajimahdi, and Shohreh Mohebbi, and Hootesa Rashidi, and Sasan Mozaffari, and Sahar Sarraf, and Mehrdad Faizi, and Seyed Abbas Tabatabaee, and Abbas Shafiee
Design and synthesis of new 2-substituted-5-(2-benzylthiophenyl)-1,3,4-oxadiazoles as benzodiazepine receptor agonists.
June 2005, Bioorganic & medicinal chemistry letters,
Afshin Zarghi, and Zahra Hajimahdi, and Shohreh Mohebbi, and Hootesa Rashidi, and Sasan Mozaffari, and Sahar Sarraf, and Mehrdad Faizi, and Seyed Abbas Tabatabaee, and Abbas Shafiee
Synthesis of some new 2-(substituted-phenyl)-5-(N,N-diphenylaminomethyl)-1,3,4-oxadiazoles: a safer anti-inflammatory and analgesic agents.
January 2011, Acta poloniae pharmaceutica,
Afshin Zarghi, and Zahra Hajimahdi, and Shohreh Mohebbi, and Hootesa Rashidi, and Sasan Mozaffari, and Sahar Sarraf, and Mehrdad Faizi, and Seyed Abbas Tabatabaee, and Abbas Shafiee
15N NMR study of substituted 2-(phenylamino)-5-phenyl-1,3,4-oxadiazoles.
February 2007, Magnetic resonance in chemistry : MRC,
Afshin Zarghi, and Zahra Hajimahdi, and Shohreh Mohebbi, and Hootesa Rashidi, and Sasan Mozaffari, and Sahar Sarraf, and Mehrdad Faizi, and Seyed Abbas Tabatabaee, and Abbas Shafiee
Synthesis and antimicrobial studies of a new series of 2-[4-[2-(5-ethylpyridin-2-yl)ethoxy]phenyl]-5-substituted-1,3,4-oxadiazoles.
July 2006, European journal of medicinal chemistry,
Afshin Zarghi, and Zahra Hajimahdi, and Shohreh Mohebbi, and Hootesa Rashidi, and Sasan Mozaffari, and Sahar Sarraf, and Mehrdad Faizi, and Seyed Abbas Tabatabaee, and Abbas Shafiee
Synthesis and Pharmacological Activities of Some New 5-Substituted-2-mercapto-1,3,4-oxadiazoles.
September 2011, Indian journal of pharmaceutical sciences,
Afshin Zarghi, and Zahra Hajimahdi, and Shohreh Mohebbi, and Hootesa Rashidi, and Sasan Mozaffari, and Sahar Sarraf, and Mehrdad Faizi, and Seyed Abbas Tabatabaee, and Abbas Shafiee
2-[3-(4-chloro/ethyl phenyl)propan-3-one]-5-(substituted phenyl)-1,3,4-oxadiazoles: synthesis and biological evaluation.
January 2008, Acta poloniae pharmaceutica,
Afshin Zarghi, and Zahra Hajimahdi, and Shohreh Mohebbi, and Hootesa Rashidi, and Sasan Mozaffari, and Sahar Sarraf, and Mehrdad Faizi, and Seyed Abbas Tabatabaee, and Abbas Shafiee
Synthesis, characterization and antibacterial activity of 2-[1-(5-chloro-2-methoxy-phenyl)-5-methyl-1H-pyrazol-4-yl]-5-(substituted-phenyl)-[1,3,4]oxadiazoles.
November 2009, European journal of medicinal chemistry,
Afshin Zarghi, and Zahra Hajimahdi, and Shohreh Mohebbi, and Hootesa Rashidi, and Sasan Mozaffari, and Sahar Sarraf, and Mehrdad Faizi, and Seyed Abbas Tabatabaee, and Abbas Shafiee
Synthesis of 2-aryl-5-(arylsulfonyl)-1,3,4-oxadiazoles as potent antibacterial and antioxidant agents.
January 2022, Turkish journal of chemistry,
Copied contents to your clipboard!